Streetbeat News

Analyst Ratings

RDN

Radian Group (NYSE:RDN) has received mixed ratings from analysts, with recent upgrades in price targets. The company's financial performance is strong, with impressive revenue growth, net margin, and return on equity. Analysts have raised their price targets, reflecting positive sentiment.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

TDOC

Teladoc Health (NYSE:TDOC) has been analyzed by 14 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $10.5, down from $16.00. Analysts have adjusted their ratings and price targets, reflecting recent developments. Teladoc faces challenges with revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

HSIC

Henry Schein (NASDAQ:HSIC) has received mixed analyst ratings over the past three months, with most analysts being somewhat bullish. The average 12-month price target has decreased to $79.25 from $81.50. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Henry Schein's financials show a strong market presence, with a net margin of 3.32% and a debt-to-equity ratio of 0.81, but challenges in revenue growth and return on equity.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

MBX

JP Morgan has initiated coverage on MBX Biosciences with an Overweight rating and set a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:57 pm

WEC

Barclays analyst Eric Beaumont maintains an Underweight rating on WEC Energy Group but raises the price target from $86 to $89.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:52 pm

SLM

Barclays analyst Mark Devries has maintained an Overweight rating on SLM Corporation (NASDAQ:SLM) and raised the price target from $23 to $27.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:50 pm

PTCT

Baird analyst Joel Beatty has reiterated an Outperform rating for PTC Therapeutics, maintaining a price target of $44.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:49 pm

RKT

Barclays analyst Terry Ma maintains an Underweight rating on Rocket Companies (NYSE:RKT) but raises the price target from $10 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:48 pm

UNH

UnitedHealth Group (NYSE:UNH) has seen a surge in options activity, with a significant number of bullish trades. This unusual activity suggests potential upcoming developments. Analysts have set an average price target of $591, and the stock is currently trading at $581, down 0.44%.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:46 pm

RDN

Barclays analyst Mark Devries maintains an Equal-Weight rating on Radian Group (NYSE:RDN) and raises the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 5:44 pm